Adverse events11

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 11 of 11

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hypotension	Vascular disorders	Sparsentan	7	48
other	Headache	Nervous system disorders	Sparsentan	4	48
other	Oedema	General disorders	Sparsentan	4	48
other	Oedema peripheral	General disorders	Sparsentan	4	48
other	Upper respiratory tract infection	Infections and infestations	Sparsentan	4	48
other	Dizziness	Nervous system disorders	Sparsentan	3	48
serious	Osteoarthritis	Musculoskeletal and connective tissue disorders	Sparsentan	1	48	1
serious	Cerebrovascular event	Nervous system disorders	Sparsentan	1	48	1
serious	Acute kidney injury	Renal and urinary disorders	Sparsentan	1	48	1
serious	Deep vein thrombosis	Vascular disorders	Sparsentan	1	48	1
serious	Chemical burn	Injury, poisoning and procedural complications	Sparsentan	1	48	1

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNone stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05856760/events